1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
Delayed Nasdaq  -  04:00 2022-06-24 pm EDT
144.27 USD   +0.71%
06/26Moderna Seeks Swissmedic's Approval Extension For COVID-19 Jab Against Omicron
MT
06/25Pfizer says tweaked COVID-19 shots boost omicron protection
AQ
06/24INSIDER SELL : Moderna
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Piper Sandler Adjusts Moderna's Price Target to $214 From $348, Reiterates Overweight Rating

05/18/2022 | 04:51am EDT


© MT Newswires 2022
All news about MODERNA, INC.
06/26Moderna Seeks Swissmedic's Approval Extension For COVID-19 Jab Against Omicron
MT
06/25Pfizer says tweaked COVID-19 shots boost omicron protection
AQ
06/24INSIDER SELL : Moderna
MT
06/24Moderna COVID-19 shots now an option for older kids in US
AQ
06/24U.S. CDC backs Moderna's COVID vaccine for teens, older children
RE
06/24The next COVID booster shots will likely be updated for Omicron
RE
06/24Sanofi, GSK variant-specific COVID shot found effective against Omicron
RE
06/24US Public Health Agency Advisers Recommend Moderna's COVID-19 Jab For Ages Six to 17
MT
06/24MODERNA, INC.(NASDAQGS : MRNA) added to Russell 1000 Value-Defensive Index
CI
06/24MODERNA, INC.(NASDAQGS : MRNA) added to Russell 1000 Growth-Defensive Index
CI
More news
Analyst Recommendations on MODERNA, INC.
More recommendations
Financials (USD)
Sales 2022 22 079 M - -
Net income 2022 11 509 M - -
Net cash 2022 18 531 M - -
P/E ratio 2022 5,29x
Yield 2022 -
Capitalization 57 385 M 57 385 M -
EV / Sales 2022 1,76x
EV / Sales 2023 3,54x
Nbr of Employees 2 700
Free-Float 90,6%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Last Close Price 144,27 $
Average target price 213,67 $
Spread / Average Target 48,1%
EPS Revisions
Managers and Directors
Stéphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.-43.20%57 385
IQVIA HOLDINGS INC.-24.22%40 468
LONZA GROUP AG-32.67%39 851
SEAGEN INC.16.00%33 010
CELLTRION, INC.-13.38%18 371
ICON PUBLIC LIMITED COMPANY-28.76%17 936